AzTrials
AzTrials

Eating BehaviorNCT05486442

ACT for Weight-related Experiential Avoidance

A study testing ACT for weight-related experiential avoidance in people with Eating Behavior, run by Bahcesehir Cyprus University at 1 site in Cyprus.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aimed to investigate whether Acceptance and Commitment Therapy/Training would be helpful to reduce weight-related experiential avoidance among individuals who reported weight concern Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Eating Behavior
What is being tested?
ACT for weight-related experiential avoidance
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 siteCyprus
Study dates
4 Mar 2022to 3 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Individuals who were 18 years and older
  • Ability to read and understand Turkish

Who cannot join

  • Individuals who have received mental health intervention over the last one year
  • and those who were diagnosed with an eating disorder were excluded from the analyses

Trial locations and contacts

1 site in 1 country.

Cyprus1 site
  • Near East University

    Nicosia

Other trials in Cyprus

About this study

Official title: Acceptance and Commitment Training for Weight-related Experiential Avoidance

This study aimed to investigate whether Acceptance and Commitment Therapy/Training would be helpful to reduce weight-related experiential avoidance among individuals who reported weight concern

Read the detailed description

This quasi-experimental study aimed to examine the efficacy of Acceptance and Commitment Therapy/Training (ACT) in reducing weight-related experiential avoidance. Data were collected with a convenience sampling technique. After obtaining ethical approval, participants were invited to participate in the study via advertisements, and online posts. Due to the small sample size, participants who were willing to attend group discussions were included in the experimental group. Participants in the control group did not receive manipulation. All participants were provided with an informed consent form. All participants completed a questionnaire measuring outcomes (weight-related experiential avoidance, general experiential avoidance, eating attitudes, and social physique anxiety) at pre-test, post-test, and follow-up. Participants in the experimental group received ACT training including 6 sessions. The protocol was adapted from Pearson et al. (2012) with their permission. Each session took approximately 80 mins. Several aspects of ACT approach were discussed in the sessions. In session one, ACT approach was introduced. In session two, creative hopelessness was discussed. In session three, control strategies related to weight concern were identified. In session four, mindfulness exercises were completed. In the fifth session, values for meaningful life experience were discussed. In the last, sixth session, the ways to commit to action were discussed. Each session included exercises and homework. At the end of the study, the participants were provided with debrief form.

Conditions
Eating Behavior
Being tested
ACT for weight-related experiential avoidance
Medical subject headings
Feeding Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ACT for weight-related experiential avoidanceBehavioural

    Participants in the experimental group received weight concern-related ACT training in a group setting. Each session focused on different dimensions of ACT and included relevant exercises and homeworks. Dimensions studied included creative hopelessness, control strategies, mindfulness exercises, values and barries to values and commitment to action.

Study groups in NCT05486442
Study groupRoleWhat they receive
Experimental groupExperimentalParticipants in the experimental group received ACT training in the group setting aiming to reduce weight-related experiential avoidance. This included 6 sessions in total. Each session was completed approximately in 80 mins.
Receives: Behavioral: ACT for weight-related experiential avoidance
Control groupNo interventionParticipants in the control group did not receive any manipulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in weight-related experiential avoidance

    It was measured by Acceptance and Action Questionnaire for Weight-Related Difficulties-Revised. The scale includes 10 items that are rated on 7 points scale (1 = not true at all - 7 = completely true). Higher scores indicate greater weight related experiential avoidance.

    Measured: At three time points (pre-intervention [baseline], immediately after the intervention, and at three weeks after the intervention)

Secondary outcomes (3)
  1. Change in eating attitudes

    Eating attitudes were measured by The Eating Attitudes Test-26. It includes 26 items that are rated on 4 point scale ('3 = Always, 2 = Usually, 1 = Often, 0 = Sometimes, Rarely, and Never'). The last item (26) requires reverse coding. Scores 20 and above indicate dysfunctional eating attitudes.

    Measured: At three time points (pre-intervention [baseline], immediately after the intervention, and at three weeks after the intervention)

  2. Change in general experiential avoidance

    It was measured by Acceptance and Action Questionnaire-II. It includes 7 items that are rated on 7 point scale (1 = never true - 7 = always true). Minimum and maximum scores range between 7 and 49 points. Higher scores indicate greater general experiential avoidance (psychological inflexibility).

    Measured: At three time points (pre-intervention [baseline], immediately after the intervention, and at three weeks after the intervention)

  3. Change in social physique anxiety

    It was measured by The Social Physique Anxiety Scale. The scale includes 12 items are rated on a 5-point scale (1=not at all true to 5=extremely true). Higher scores indicate a higher level of anxiety related to the social physique. Only item 1, 2, 5, 8 and 11 requires reverse coding.

    Measured: At three time points (pre-intervention [baseline], immediately after the intervention, and at three weeks after the intervention)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Aug 2022
  2. Study start4 Mar 2022
  3. Primary completion3 Jun 2022
  4. Study completion3 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05486442
Sponsor's protocol ID
NEU/SS/2022/1208
Status last verified
Aug 2022
First submitted
30 Jul 2022
Last updated
3 Aug 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Pearson, Adria N., Victoria M. Follette, and Steven C. Hayes.

Questions about this trial

What is this clinical trial studying?

A study testing ACT for weight-related experiential avoidance in people with Eating Behavior, run by Bahcesehir Cyprus University at 1 site in Cyprus.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Cyprus. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in weight-related experiential avoidance (time frame: At three time points (pre-intervention [baseline], immediately after the intervention, and at three weeks after the intervention)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05486442, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in